JP2022532734A5 - - Google Patents

Info

Publication number
JP2022532734A5
JP2022532734A5 JP2021568113A JP2021568113A JP2022532734A5 JP 2022532734 A5 JP2022532734 A5 JP 2022532734A5 JP 2021568113 A JP2021568113 A JP 2021568113A JP 2021568113 A JP2021568113 A JP 2021568113A JP 2022532734 A5 JP2022532734 A5 JP 2022532734A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
mucosal tissue
compound
anatomical region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021568113A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532734A (ja
JP7770191B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/032547 external-priority patent/WO2020232037A1/en
Publication of JP2022532734A publication Critical patent/JP2022532734A/ja
Publication of JP2022532734A5 publication Critical patent/JP2022532734A5/ja
Priority to JP2025076668A priority Critical patent/JP2025118765A/ja
Application granted granted Critical
Publication of JP7770191B2 publication Critical patent/JP7770191B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021568113A 2019-05-16 2020-05-12 カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のための抗真菌剤 Active JP7770191B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025076668A JP2025118765A (ja) 2019-05-16 2025-05-02 カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のためのイブレクサファンゲルプのような抗真菌剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962849019P 2019-05-16 2019-05-16
US62/849,019 2019-05-16
PCT/US2020/032547 WO2020232037A1 (en) 2019-05-16 2020-05-12 Antifungal agents, like ibrexafungerp for candida auris decolonization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025076668A Division JP2025118765A (ja) 2019-05-16 2025-05-02 カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のためのイブレクサファンゲルプのような抗真菌剤

Publications (3)

Publication Number Publication Date
JP2022532734A JP2022532734A (ja) 2022-07-19
JP2022532734A5 true JP2022532734A5 (https=) 2023-06-21
JP7770191B2 JP7770191B2 (ja) 2025-11-14

Family

ID=70861571

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021568113A Active JP7770191B2 (ja) 2019-05-16 2020-05-12 カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のための抗真菌剤
JP2025076668A Withdrawn JP2025118765A (ja) 2019-05-16 2025-05-02 カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のためのイブレクサファンゲルプのような抗真菌剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025076668A Withdrawn JP2025118765A (ja) 2019-05-16 2025-05-02 カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のためのイブレクサファンゲルプのような抗真菌剤

Country Status (14)

Country Link
US (1) US20220211684A1 (https=)
EP (1) EP3968986A1 (https=)
JP (2) JP7770191B2 (https=)
KR (1) KR20220009416A (https=)
CN (1) CN113905733A (https=)
AU (1) AU2020276595B2 (https=)
BR (1) BR112021022876A2 (https=)
CA (1) CA3140637A1 (https=)
EA (1) EA202193146A1 (https=)
IL (1) IL288165B1 (https=)
MA (1) MA55958A (https=)
MX (1) MX2021013899A (https=)
TW (2) TWI881977B (https=)
WO (1) WO2020232037A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250006380A (ko) 2023-07-03 2025-01-13 연세대학교 산학협력단 칸디다 아우리스에 대한 항진균제 스크리닝 방법 및 항진균용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
DK2007396T3 (da) 2006-04-03 2013-03-18 Merck Sharp & Dohme Enfumafungin-derivat som antimykotika
RS53731B1 (sr) * 2008-08-12 2015-06-30 Scynexis, Inc. Antigljivični agensi
US8188085B2 (en) 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
WO2017161016A1 (en) * 2016-03-16 2017-09-21 Cidara Therapeutics, Inc. Dosing regimens for treatment of fungal infections
EP3609539A1 (en) * 2017-04-10 2020-02-19 Scynexis, Inc. Antifungal agents used in combination
US20200291488A1 (en) 2017-05-17 2020-09-17 T2 Biosystems, Inc. Nmr methods and systems for the rapid detection of candida species
EP4732902A2 (en) * 2017-08-04 2026-04-29 Scynexis, Inc. Antifungal agents with enhanced activity in acidic ph
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques

Similar Documents

Publication Publication Date Title
TW200538115A (en) New pharmaceutical compositions for the treatment of sexual disorders
JP2006523216A5 (https=)
JP6883578B2 (ja) テトラサイクリンの塩
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
JP2010522714A (ja) 新規な医薬組成物
JP2004517843A5 (https=)
JP2023030113A5 (https=)
JP2023548190A5 (https=)
JP2019529460A5 (https=)
JP2007169278A (ja) Ｌｕｔｓ処置用の医薬組合せ
CN100361975C (zh) 5－羟基－3－羧酸酯吲哚类衍生物及其制备方法
JP2021534160A5 (https=)
JP2022532734A5 (https=)
CN103833712B (zh) 硝克柳胺化合物晶ii型、其制法和其药物组合物与用途
JP2003516346A5 (https=)
WO2020117755A1 (en) Compositions and methods for treating biofilms
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
JP2007525533A5 (https=)
CN1761665A (zh) 抗肿瘤效果增强剂和抗肿瘤剂
JP2020529999A5 (https=)
JP2020513037A5 (https=)
JP2023531930A5 (https=)
CA2464309A1 (en) Combinations comprising a selective cyclooxygenase-2 inhibitor
JP2025118765A (ja) カンジダ・アウリス（Ｃａｎｄｉｄａ ａｕｒｉｓ）脱コロニー化のためのイブレクサファンゲルプのような抗真菌剤
WO2020067333A1 (ja) 線維症治療用医薬組成物